Gynecologic Oncology: Virtual Special Issue


Gynecologic Oncology is devoted to the publication of the highest quality new research, commentary and review articles that concern tumors of the female reproductive tract.  As the official journal of the Society of Gynecologic Oncology (SGO), we are marking the 2015 Annual Meeting on Women's Cancer by compiling some of the most important papers we have published in the last 12 months.  These articles highlight research and advancements which impact how we treat women with gynecologic malignancies and understand tumor biology.

This special issue includes guidance papers from the SGO, as well as papers that look to the future, to patterns of care, to genetics and to emerging therapies.  You will have free access to these papers for six months, and we hope they will encourage further discussion and collaboration throughout the field of gynecologic oncology.

Virtual special issue - Articles:

Endometrial cancer: A review and current management strategies: Part I
William M. Burke, James Orr, Mario Leitao, Emery Salom, Paola Gehrig, Alexander B. Olawaiye, Molly Brewer, Dave Boruta, Jeanine Villella, Tom Herzog, Fadi Abu Shahin
Volume 134, Issue 2, August 2014, Pages 385–392

Endometrial cancer: A review and current management strategies: Part II
William M. Burkea, b, , , James Orrc, Mario Leitaod, Emery Salome, Paola Gehrigf, Alexander B. Olawaiyeg, Molly Brewerh, Dave Borutai, Jeanine Villellaj, k, Tom Herzogl, Fadi Abu Shahinm
Volume 134, Issue 2, August 2014, Pages 393–402

Ovarian cancer screening-Current status, future directions
Usha Menon, , Michelle Griffin1, Aleksandra Gentry-Maharaj
Volume 132, Issue 2, February 2014, Pages 490–495

PARP inhibitors in ovarian cancer: Current status and future promise
Joyce F. Liu, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis
Volume 133, Issue 2, May 2014, Pages 362–369

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Thomas J. Herzoga, , Deborah K. Armstrongb, Mark F. Bradyc, Robert L. Colemand, Mark H. Einsteine, Bradley J. Monkf, g, Robert S. Mannelh, J. Tate Thigpeni, Sharee A. Umpierrej, Jeannine A. Villellak, Ronald D. Alvarezl
Volume 132, Issue 1, January 2014, Pages 8–17

Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma-Mechanistics, review of phase III randomized clinical trials, and regulatory implications
Ramez N. Eskander , Krishnansu S. Tewari
Volume 132, Issue 2, February 2014, Pages 496–505

MEK1/2 inhibitors in the treatment of gynecologic malignancies
Caela R. Millera, Kate E. Oliverb, John H. Farleyc
Volume 133, Issue 1, April 2014, Pages 128–137

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions
Johnathan M. Lancastera, , , C. Bethan Powellb, c, Lee-may Chenc, Debra L. Richardsond
Volume 136, Issue 1, January 2015, Pages 3–7

Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients
Alaina J. Brown, Charlotte C. Sun, Lauren S. Prescott, Jolyn S. Taylor, Lois M. Ramondetta, Diane C. Bodurka
Volume 135, Issue 2, November 2014, Pages 244–248

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
Rudy S. Suidana, Pedro T. Ramirezb, Debra M. Sarasohnc, Jerrold B. Teitcherc, Svetlana Mironovc, Revathy B. Iyerd, Qin Zhoue, Alexia Iasonose, Harold Paula, Masayoshi Hosakab, Carol A. Aghajanianf, g, Mario M. Leitao Jr.a, g, Ginger J. Gardnera, g, Nadeem R. Abu-Rustuma, g, Yukio Sonodaa, g, Douglas A. Levinea, g, Hedvig Hricakc, Dennis S. Chia, g
Volume 134, Issue 3, September 2014, Pages 455–461

Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status
Robert E. Bristowa,  Jenny Changb, Argyrios Ziogasb, Hoda Anton-Culverb, Veronica M. Vieirab
Volume 134, Issue 1, July 2014, Pages 60–67

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wrighta, , , Mark H. Stolerb, , Catherine M. Behrensc, , Abha Sharmac, , Guili Zhangc, , Teresa L. Wrightd
Volume 136, Issue 2, February 2015, Pages 189–197